Monte Rosa Therapeutics (GLUE) Operating Leases (2022 - 2026)
Monte Rosa Therapeutics' Operating Leases was $33.36 million in Q2 2026, down 9.9% from $37.04 million a year earlier and down 3.5% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Monte Rosa Therapeutics came in at $34.79 million, down 10.8% from FY2024.
- Operating Leases has now declined for three consecutive years, with a three-year compound annual growth rate of -7.4% (FY2022 to FY2025).
- In earlier years, Operating Leases was $39 million in FY2024 (-9.0%), $42.88 million in FY2023 (-2.3%) and $43.87 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q1 2022.
- Compared with a year earlier, Operating Leases has declined for 11 straight quarters, with an average decline of 9.5% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q1 2023 (growth of 693.0%); the worst was Q4 2025 (a decline of 10.8%).
- Per Business Quant data, GLUE's Operating Leases in the three quarters before Q2 2026 was $34.58 million (Q1 2026), $34.79 million (Q4 2025) and $35.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Monte Rosa Therapeutics | 1.08 Bn | 490.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.36 Mn |
| Mar 31, 2026 | 34.58 Mn |
| Dec 31, 2025 | 34.79 Mn |
| Sep 30, 2025 | 35.93 Mn |
| Jun 30, 2025 | 37.04 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 40.05 Mn |
| Jun 30, 2024 | 40.89 Mn |
| Mar 31, 2024 | 41.84 Mn |
| Dec 31, 2023 | 42.88 Mn |
| Sep 30, 2023 | 43.52 Mn |
| Jun 30, 2023 | 44.37 Mn |
| Mar 31, 2023 | 43.28 Mn |
| Dec 31, 2022 | 43.87 Mn |
| Sep 30, 2022 | 42.59 Mn |
| Jun 30, 2022 | 46.10 Mn |
| Mar 31, 2022 | 5.46 Mn |
API Access
Monte Rosa Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();